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Introduction 
The discussion has continued concerning Calorie Restriction 
(CR) and Low Carbohydrate Diet (LCD) for years [1-5]. Clinical 
predominance of LCD has been gradually known and more prevalent. 
In European and North American region, Atkins and Bernstein 
originally have begun to introduce LCD [6,7]. 
On contrast in Japan, the authors have started LCD, and reported 
thousands of cases with clinical efficacy [8,9]. Furthermore, we have 
investigated related research concerning 3 types of LCD formular 
meals, elevated ketone bodies, Morbus (M) value, lipid metabolism and 
renal function [10-12].
Through our clinical study, we always compared the differences 
of the glucose variability between CR and LCD. In this study, we have 
given CR diet to the patients with type 2 diabetes mellitus (T2DM), and 
investigated the responses of blood glucose, immunoreactive insulin 
(IRI) value and insulinogenic index (IGI), suggesting the usefulness of 
experimental application of IGI as an approach for clinical study.
Methods
The subjects enrolled in this study were 48 patients (M/F 23/25) 
with T2DM. They are 18-84 years old with 59.4 ± 12.9 (mean ± SD) 
years old in average, 60.5 years old in median value. 
Subjects were admitted for 14 days for further evaluation and 
treatment of T2DM. The protocol of diet therapy was as follows: 1) 
Calorie Restriction (CR) diet was provided on days 1 and 2, which had 
60% carbohydrate, 25% lipids and 15% protein with 1400 kcal/day. 2) 
Low Carbohydrate Diet (LCD) was provided from 3 to 14 days, which 
had 12% carbohydrates, 64% lipids and 24% protein with 1400 kcal/
day. This LCD has been so-called “super-LCD formula” in our clinical 
research for LCD, which is one of the very low-carbohydrate ketogenic 
diet (VLCKD) by the definitions of LCD [12-14].
Methods included the measurements of responses for glucose and 
IRI against 70 g of carbohydrate on the morning of day 2. CR diet 
has 840 kcal of carbohydrate per day, which equals totally 210 g of 
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Abstract
Background: The discussion has continued concerning Calorie Restriction (CR) and Low Carbohydrate Diet 
(LCD) for years. Authors and colleagues have continued clinical research on LCD. In this study, CR diet was given 
to diabetic patients and the new evaluation way of insulinogenic index-carbohydrate 70 g (IGI-carbo70) would be 
proposed.
Subjects and methods: The subjects were 48 patients with Type 2 diabetes mellitus (T2DM) and admitted for 
14 days for further evaluation and treatment. CR diet was provided on day 1 and 2, including 60% carbohydrate, 25% 
lipids and 15% protein with 1400 kcal/day. On the morning of day 2, breakfast with 70 g of carbohydrate was given, and 
blood glucose and immune reactive insulin (IRI) at 0 and 30 min and IGI were investigated.
Results: Average HbA1c was 7.9% and Morbus (M) value was 108 in median. Glucose and IRI on 0-30 min 
significantly increased as 166-212 mg/dL, 4.3-1.9 μU/mL, respectively. Classified into 3 groups as to HbA1c level, low, 
middle and high group showed HbA1c 6.0%, 7.8%, 9.7%, respectively. Glucose and IRI on 0-30 min in median were 
117-50, 166-203, 218-299 mg/dL, 4.4-12.8, 4.5-13.5, 4.2-9.9 μU/mL, with IGI 0.25, 0.14, 0.10, respectively. 
Discussion and conclusion: Newly-proposed IGI-carbo70 was investigated, and there were several correlations 
among 8 related biomarkers. These findings suggest that current results would become the fundamental data and IGI-
carbo70 could be the useful way to evaluate diabetic status by usual meal with mixed nutrients.
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carbohydrate in 3 meals. Then, breakfast including 70 g of carbohydrate 
was given to the patients after overnight fasting, with the measurement 
of blood glucose and IRI on 0 min and 30 min. Other blood biomarkers 
were measured in fasting on day 2.
The content of CR diet is along the guideline of Japan Diabetes 
Society, in which PFC ratio is 14.7%, 26.9%, 58.4%, respectively [15]. 
This ratio has been stable from 1985 to 2015 on the national survey in 
Japan [16].
Glucose profile and M value
On day 2, daily profile of blood glucose was studied 7 times a day, 
which are 8, 10, 12, 14, 17, 19, 22 h. According to the glucose level, 2 
markers were calculated. One is the average glucose level, and another 
is Morbus (M) value. M value is a useful index representing both blood 
sugar level and mean amplitude of glycemic excursions (MAGE) [17-
19]. As for the glucose variability, daily profiles of blood glucose were 
measured 7 times a day, and obtained data were calculated for average 
glucose level and Morbus (M) value. M value has been proposed for 
researching MAGE. This index has been calculated as a logarithmic 
transformation of the deviation of glycemia from an arbitrary assigned 
“ideal” glucose value, with an expression of both the mean glucose 
value and the effect of glucose swings [17-20].
3BS BS PGM - value = | M | +W / 20 where M =|10log |
N BS BS 120
∑
M value is calculated by the formula as follows: M=MBS+MW, where 
MW=(maximum blood glucose-minimum glucose)/20; MBS=the mean 
of MBSBS; MBSBS=individual M-value for each blood glucose value 
calculated as (absolute value of [10×log (blood glucose value/120)])3.
As to the interpretation of M value, the standard range is <180, 
borderline is 180-320 and abnormal is >320. Adequate sampling times 
a day have been argued for the detail and precise evaluation of glucose 
variability and MAGE. There were similar results on 7 times or 20 times 
of sampling per day [17-21] showing similar result in comparison with 
continuous glucose monitoring (CGM) [19-22].
Statistical analyses
In this study, obtained data was represented as the mean ± standard 
deviation (SD) and also represented median, quartile of 25% and 75% 
in biomarkers. For statistical analyses, correlation coefficients were 
calculated using Pearson or Spearman test of the Microsoft Excel 
analytical tool, which is Four steps Excel Statistics 4th edition [23].
Intergroup comparisons were made using the Wilcoxon rank sum 
test or the Bonferroni multiple comparison (Lambert method). A 
significance level of less than 5% obtained using a two-tailed test was 
considered to be statistically significant.
Ethical considerations
Current study was conducted in compliance with the ethical 
principles of the Declaration of Helsinki and Japan’s Act on the 
Protection of Personal Information along with the Ministerial 
Ordinance on Good Clinical Practice (GCP) for Drug (Ordinance of 
Ministry of Health and Welfare No. 28 of March 27, 1997). No ethical 
committee meeting was held. Informed consent was obtained from the 
subjects. The study was registered with UMIN #R000031211.
Results
Basal data
The basal data of 48 patients enrolled were shown in Table 1. The 
values are expressed by average, standard deviation and median (25%-
75%). The average age was 59.4 years old, and average HbA1c was 7.9%. 
M value obtained from the daily profile of glucose on day 2 was 108 
34.1-308 median 25%-75%.
Carbohydrate loading
Biomarkers data related to 70 g of carbohydrate intake were shown 
in Table 2. The values are expressed by the average, standard deviation, 
median and quartile of 25% and 75%. Responses of glucose and IRI 
against 70 g of carbohydrate were shown in Figure 1. Number of the 
subjects is 48. There was significant difference between glucose increase 
at 0 and 30 minutes, and between IRI increase at 0 and 30 minutes 
(p<0.01).
IGI-carbo70 in 3 groups
Glucose increase against carbohydrate 70 g was investigated in 
3 groups (Figure 2). Subjects were classified into 3 groups according 
to HbA1c value. They are low, middle and high group, which HbA1c 
was 6.0 ± 0.5%, 7.8 ± 0.6%, 9.7 ± 0.9%, respectively. Each group has 16 
subjects and showed significant glucose increase between 0 min and 30 
min (p<0.01). In 3 groups, glucose on 0 min and 30 min in median were 
117-150, 166-203, 218-299 mg/dL, respectively.
 Mean ± SD Median 25%-75%
Age (years old) 59.4 ± 12.9 60.5 54.5-68.3
HbA1c (%) 7.9 ± 1.7 8.1 6.4 - 8.9
Average Glucose (mg/dL) 196.3 ± 81.3 174.3 147-241
Morbus Value 207.3 ± 258 108 34.1-308
Triglyceride (mg/dL) 184.4 ± 239 101.5 70.8 -202
HDL-C (mg/dL) 66.8 ± 20.5 63.5 10.0-79.8
LDL-C (mg/dL) 140.4 ± 43.9 138.5 109-165
HOMA-R 2.0 ± 1.1 1.9 1.1-2.5
HOMA-β 21.6 ± 17.6 16.7 10.6-25.7
Table 1: Basal Data of Patient with T2DM.
 Mean ± SD Median 25%-75%
Glucose 0 min (mg/dL) 169.1 ± 54.1 166 124-212
Glucose 30 min (mg/dL) 215.3 ± 64.1 212 160-269
IRI 0 min (µU/mL) 4.8 ± 2.2 4.3 3.0-6.2
IRI 30 min (µU/mL) 13.6 ± 9.8 11.9 7.8-18.0
Glucose Increase (mg/dL) 46.2 ± 25.5 36.5 29.0-63.5
IRI increase (µU/mL) 8.8 ± 8.7 7.3 3.5-10.8
IGI-Carbo70 0.28 ± 0.35 0.12 0.09-0.32
Table 2: Biomarker Related to Carbon-70.
Figure 1: Responses of glucose and IRI against carbohydrate load of 70 g.
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Similarly, IRI increase against carbohydrate 70 g was investigated in 
3 groups (Figure 3). Each group has 16 subjects and showed significant 
IRI increase between 0 min and 30 min (p<0.01). IRI on 0 min and 
30 min in median were 4.4-12.8, 4.5-13.5, 4.2-9.9 μU/mL, respectively.
Data from Figures 2 and 3, Insulinogenic Index (IGI)-carbohydrate 
70 g (IGI-carbo70) was calculated and classified in 3 groups (Figure 4). 
The median level was decreased from low, medium and high group, 
with 0.25, 0.14 and 0.10, respectively.
Correlation of IGI-carbo70
Mutual correlations among IGI-carbo70 and other biomarkers 
were investigated (Table 3). IGI-carbo70 showed significant correlation 
with increment of glucose and IRI, and HOMA-β. M value showed 
significant correlation with basal glucose, increment of glucose and IRI, 
HOMA-R and HOMA-β.
Discussion
Insulinogenic index (IGI) has been useful marker which measures 
the ratio of insulin increment to glucose increment in 75 g OGTT at 30 
min [24,25]. Recent study revealed that the average IGI was 1.00, 0.69 
and 0.46 in 3 groups which were group of normal glucose tolerance 
(NGT), group with fasting glucose 100-109 mg/dL, group with fasting 
glucose 110-125 mg/dL [26]. Another study revealed that average IGI 
was 1.02 in 1265 normal young volunteers and 0.80 in 1076 obese 
Figure 2: Glucose elevation against carbohydrate load of 70 g in 3 groups.
Figure 3: IRI elevation against carbohydrate load of 70 g in 3 groups.
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Figure 4: IGI-carbo70 in three groups.
  
Basal Increment
IGI-Carbo70 MorbusValue
HOMA
Glucose IRI Glucose IRI -R -β  
Basal Glucose
-0.027 0.261 -0.13 -0.215 0.866 0.502 -0.755 C.C.
P.V.0.854 0.067 0.365 0.132 <0.001 <0.001 <0.001
Basal IRI 
-0.027 -0.002 0.507 0.439 -0.117 0.849 0.59
0.854 0.989 <0.001 0.002 0.414 <0.001 <0.001
Increment Glucose
 0.261 -0.002 -0.014 -0.465 0.42 0.115 -0.123
 0.067  0.989 0.924 0.001 0.003 0.431 0.398
Increment IRI 
-0.13 0.507 -0.014 0.852 -0.3 0.348 0.352
0.365 <0.001 0.924 <0.001 0.036 0.017 0.016
IGI 
-0.215 0.439 -0.465 0.852  
 
-0.456 0.256 0.349
0.132 0.002 0.001 <0.001 0.001 0.079 0.017
M value 
0.866 -0.117 0.42 -0.3 -0.456  
 
0.295 -0.734
<0.001 0.414 0.003 0.036 0.001 0.043 <0.001
HOMA-R  
0.502 0.849 0.115 0.348 0.256 0.295 0.132
<0.001 <0.001 0.431 0.017 0.079 0.043 0.367
HOMA-β 
-0.755 0.59 -0.123 0.352 0.349 -0.734 0.132
<0.001 <0.001 0.398 0.016 0.017 <0.001 0.367  
C.C: Correlation coefficient; P.V: P value; IGI-carbo70: Insulinogenic Index-carbo70; HOMA-R: Homeostasis Model Assessment Insulin Resistance; HOMA-β: Homeostasis 
Model Assessment for β Cell Function; IRI: Immuno-reactive Insulin.
Shadow areas represent significant correlations including <0.05, <0.01 and <0.001.
Table 3: Correlation among 8 related factors.
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children/adolescents [27]. As to T2DM with and without aggravation 
of parameters, IGI in average was showed 0.3 and 0.5, respectively [28].
Furthermore, IGI has been used after a meal at 30 min [29-31]. The 
changes in IGI were correlated to the changes in the β-cell function 
in both normal glucose-tolerant and prediabetic individuals, which 
suggests it to be a valid proxy indicator for β-cell function in healthy 
individuals [29].
In Asian countries, overconsumption of starchy foods such as rice 
has induced a rapid and sharp postprandial hyperglycemia [32-34]. 
This increased glucose response is accompanied by an insulin surge and 
contributes to the etiology of diabetes [35]. 
Recently, effect of co-ingestion of amino acids with rice on glycemic 
and insulin response was investigated in 7 various patterns [36]. Rice 
with 68 mL of amino acid mixture showed the best results in reducing 
the peak blood level [36]. Its merit lies in enabling people living in Asia 
to reduce postprandial hyperglycemia due to carbohydrate-rich rice 
meals by the inclusion of a ready-to-drink amino acid mixture [37-39].
A liquid mixed meal test was tried for the indices of insulin 
secretion in patients with diabetes [40]. Participants ingested 237 mL 
high protein boost-HP (Nestle) consisting of 33 g carbohydrate, 15 g 
protein and 6 g fat, (%Calories: 55% carbohydrate, 25% protein, and 
20% fat). IGI and also C-peptide-derived 30 minutes index and oral 
disposition index (ODI) from the mixed meal would be useful [41-43].
The effect of a rice bowl topped with beef to blood glucose was 
investigated [44]. This is one of famous Japanese fast food with protein 
18.4 g, fat 20.9 g and carbohydrate 82.9 g, and it was given to 12 healthy 
volunteers with 26.9 years old in average. Blood glucose increased 65 
mg/dL at 30 min. Thus, even if the subjects are healthy, blood glucose 
increase seems to be remarkable. 
Ethnic difference for IGI was investigated using two 200 mL 
servings of Ensure Plus (Abbott Laboratories, Columbus, OH, USA) 
[45]. Each serving has 300 kcal, 40.4 g carbohydrate, 9.8 g fat and 12.5 
g protein. Chinese, Malay and Asian Indians showed 36-45 mg/dL 
increase of blood glucose at 30 min, and its IGI was 0.64, 0.266 and 
0.399, respectively.
Conclusion
Taking these results and discussion into consideration, research 
for postprandial hyperglycemia with mixed-nutrient load would be 
significant. Newly-proposed IGI-carbo70 was investigated, and there 
were several correlations among 8 related biomarkers. These findings 
suggest that current results would become the fundamental data and 
IGI-carbo70 could be the useful way to evaluate diabetic status by usual 
meal with mixed nutrients. 
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